ArticleEye (London, England)2023

Characterising treatment outcomes of patients achieving quarterly aflibercept dosing for neovascular age-related macular degeneration: real-world clinical outcomes from a large tertiary care centre.

Dun Jack Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.